Amgen Highlights The Latest EVENITY™ (Romosozumab) And Prolia® (Denosumab) Research At The American Society For Bone And Mineral Research Annual Meeting

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. TTAN
2. CHYM
3. BRZE
4. USO
5. QCOM
6. DYN
7. PHVS
8. NOVN:SW
9. USB
10. NVS

Go back to Amgen Highlights The Latest EVENITY™ (Romosozumab) And Prolia® (Denosumab) Research At The American Society For Bone And Mineral Research Annual Meeting
Amgen Inc (NASDAQ: AMGN) Delayed: 393.17 --0 (-0%)
Previous Close $393.17    52 Week High $176.85 
Open $393.17    52 Week Low $133.64 
Day High $393.17    P/E 59.21 
Day Low $393.17    EPS $6.64 
Volume 4,693